Related Experiment Video
Updated: Jan 11, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Guided Inhalation via Electronic Monitoring in Children With Uncontrolled Asthma (the IMAGINE Study): Randomized
Esther Sportel1, Kris Movig1, Bernard Thio2,3
1Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, The Netherlands.
Insights
Smart inhaler feedback did not improve pediatric asthma control compared to no feedback. However, both groups showed clinical improvements, suggesting a need for adaptive interventions in asthma management.
Area of Science:
- Pediatric Pulmonology
- Digital Health
- Clinical Trials
Background:
- Pediatric asthma is a common chronic illness in the Netherlands, with adherence and technique crucial for control.
- Current hospital visits offer limited insight into these critical parameters.
- Smart inhalers offer potential for home-based monitoring and feedback to improve asthma management.
Purpose of the Study:
- To assess if smart inhaler feedback improves asthma control by enhancing therapy adherence and inhalation technique.
- To evaluate the impact of immediate feedback on clinical outcomes in pediatric asthma patients.
Main Methods:
- The IMAGINE study was a 3-phase randomized controlled trial (RCT).
- Phases included observation, randomization with feedback (intervention) or recording only (control), and final observation.
- Asthma control was measured using lung function tests and validated questionnaires.
Main Results:
- Improvements in clinical parameters (lung function variability, Asthma Control Test scores) were seen in both groups, but no significant difference between groups.
- Predicted forced expiratory volume in 1 second did not improve.
- Inhalation technique and therapy adherence showed no significant differences between the intervention and control groups over time.
Conclusions:
- Smart inhaler feedback alone did not yield superior outcomes compared to standard care.
- Clinical improvements observed in both groups highlight the potential for smart inhaler technology.
- Future research should focus on adaptive, personalized smart inhaler interventions to enhance patient engagement and ownership in asthma management.
Background:
Pediatric asthma is the most common chronic illness among children in the Netherlands. Scheduled hospital visits provide limited insight into therapy adherence and inhalation technique, which are critical for disease control. Smart inhalers that provide immediate feedback may offer a solution for monitoring and improving these parameters at home, leading to better asthma control.
Objective:
This study aimed to improve asthma control through immediate feedback on therapy adherence and inhalation technique, with the use of a smart inhaler.
Methods:
The IMAGINE (Improving Adherence by Guiding Inhalation via Electronic Monitoring) study was a randomized controlled trial consisting of 3 phases: an observational run-in phase in which adherence and technique were recorded, a randomized phase with feedback for the intervention group and recording for the control group, followed by an observational phase with only recording for both groups. Asthma control was measured with clinical outcomes including predicted forced expiratory volume in 1 second, lung function reversibility, lung function variability, the Asthma Control Test, and the Childhood Asthma Control Test.
Results:
Between October 2019 and October 2023, a total of 34 children were enrolled and randomized. Overall, improvements were observed at the end of phase 2 in clinical parameters (reversibility, lung function variability, Asthma Control Test, and Childhood Asthma Control Test), except for predicted forced expiratory volume in 1 second. However, no significant differences between the intervention and control groups over time were observed. At the end of phase 2, 87% (13/15) of control participants and 78% (10/13) of intervention participants met one or more predefined clinical criteria. Inhalation technique and therapy adherence did not differ over time between the groups (P=.70 and P=.14, respectively).
Conclusions:
While smart inhaler feedback did not lead to better outcomes compared with no feedback, clinical improvements were observed in both groups. Future studies should explore how adaptive smart inhaler interventions can be optimized to support personalized care and enhance patient ownership in asthma management.
Trial Registration:
International Clinical Trials Registry Platform NL-OMON50093; https://tinyurl.com/yws24rxy.
International Registered Report Identifier (Irrid):
RR2-10.1186/s13063-020-04694-4.
Related Concept Videos
01:23Inhaled Medications
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Asthma-IV: Nursing Management
First, in...
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: